NewAmsterdam Pharma Co N.V. Return On Equity in % from 2023 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
NewAmsterdam Pharma Co N.V. quarterly/annual Return On Equity history and growth rate from 2023 to Q3 2025.
  • NewAmsterdam Pharma Co N.V. Return On Equity for the quarter ending September 30, 2025 was -29.1 %, a 46.4% increase year-over-year.
  • NewAmsterdam Pharma Co N.V. annual Return On Equity for 2024 was -49.9 %, a 1.81% increase from 2023.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)

NewAmsterdam Pharma Co N.V. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -29.1 +25.2 +46.4% Jul 1, 2025 Sep 30, 2025
Q2 2025 -24.6 +40 +61.9% Apr 1, 2025 Jun 30, 2025
Q1 2025 -32.6 +32.5 +50% Jan 1, 2025 Mar 31, 2025
Q4 2024 -49.9 +0.92 +1.81% Oct 1, 2024 Dec 31, 2024
Q3 2024 -54.3 Jul 1, 2024 Sep 30, 2024
Q2 2024 -64.6 Apr 1, 2024 Jun 30, 2024
Q1 2024 -65.1 Jan 1, 2024 Mar 31, 2024
Q4 2023 -50.8 Oct 1, 2023 Dec 31, 2023

NewAmsterdam Pharma Co N.V. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -49.9 +0.92 +1.81% Jan 1, 2024 Dec 31, 2024
2023 -50.8 Jan 1, 2023 Dec 31, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.